undefined undefined
NaN.000
NaN.00%
Capricor Therapeutics (NASDAQ:CAPR) has been initiated at Outperform by Oppenheimer on hopes of positive outcome from the company’s Phase 3 trial of its Duchenne muscular dystrophy treatment. CAPR sto...
05-17 22:09
Capricor Therapeutics(CAPR.US)获奥本海默首次覆盖,给予优于大市评级, 目标价14.00美元。
05-17 17:41
Unity Software(U.US) reported fourth-quarter financial results after the market...
05-17 17:36
Capricorn Energy PLC (GB:CNE) has released an update. Capricorn Energy PLC has ...
05-16 00:27
Capricorn Metals Ltd (AU:CMM) has released an update. Mitsubishi UFJ Financial ...
05-15 15:05
Capricorn Metals Ltd (AU:CMM) has released an update. Capricorn Metals Ltd anno...
05-15 07:28
During the last three months, 5 analysts shared their evaluations of Capricor T...
05-15 03:01
Capricorn Energy PLC (GB:CNE) has released an update. Capricorn Energy PLC has ...
05-14 22:47
Capricor Therapeutics (NASDAQ:CAPR) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.11) by 181.82 percent. This is unchanged from the same period last year. The company
05-14 04:16
来源:北京商报 当地时间5月9日,轻奢品牌Coach母公司Tapestry集团公布了2024财年第三季度(截至2024年3月30日的3个月)财报。报告期...
05-12 23:36